Articles
Bad times for pharma in Spain

Bad times for pharma in Spain

Government decrees and a poor economic climate in Spain have hit the pharma sector hard and the worst is yet to come, Miguel Tovar highlights the economic problems they face. During the past few years, Spain has witnessed a rapid increase in healthcare spending at a rate faster than…

Articles
What Are IDEAs Made Of: Innovation

What Are IDEAs Made Of: Innovation

Many companies focus on innovation but often without having a real focus. Mike Rea discusses true innovation and how to gauge when your ideas really count. Steven Johnson's wonderful book, Where Good Ideas Come From: The Natural History of Innovation presents a fascinating case for...

Articles
The report of the death of the international congress

The report of the death of the international congress

With the tightening of budgets and regulations, international medical congresses are facing significant challenges. Chris Stevenson considers whether it is the ‘beginning of the end’ or simply time for a new business model. In 1897 Mark Twain read his own, obviously premature, obituary in a newspaper and was driven to respond that...

Sales & Marketing

Sales & Marketing
Solution Spotlight: BrandPRO Biopharma
Sponsored

Solution Spotlight: BrandPRO Biopharma

Strong strategy on paper can unravel when priorities collide. BrandPRO Biopharma gives pharmaceutical teams a place to put their decisions to the test

Digital

Market Access

Editor's Picks

  1. UK budget includes £1bn biopharma investment package
  2. HHS doubles down on controversial peptides plan
  3. Lilly's triple G overpowers Ozempic in diabetes trial
  4. UK puts £100m into "world-first" AI biosecurity facility
  5. US gives $99m for Ebola jab project, as cases spread in Africa

Newsletters and Deep Dive
digital magazine

Oncology

more

Patients

more

R&D

more